Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Central Africa is increasing rapidly due to various reasons.
Customer preferences: The customers in Central Africa are becoming more aware of the importance of vaccines in preventing diseases. With the rise in the number of diseases and the spread of epidemics, people are increasingly looking for vaccines that can protect them from these diseases. Additionally, there is a growing trend towards preventive healthcare, which is driving the demand for vaccines.
Trends in the market: The vaccines market in Central Africa is witnessing a shift towards the use of innovative vaccines. The demand for vaccines that can provide long-term protection against diseases is increasing. There is also a growing trend towards the use of combination vaccines that can protect against multiple diseases in a single shot. This is particularly important in Central Africa, where there is a high prevalence of multiple diseases.
Local special circumstances: Central Africa is home to a large number of infectious diseases, including malaria, tuberculosis, and HIV/AIDS. The prevalence of these diseases is driving the demand for vaccines that can prevent them. Additionally, the lack of proper healthcare infrastructure in the region is making it difficult for people to access healthcare services. Vaccines are seen as a cost-effective way of preventing diseases, especially in areas where healthcare services are limited.
Underlying macroeconomic factors: The economic growth in Central Africa is driving the demand for vaccines. With the rise in income levels, people are becoming more willing to spend on healthcare services, including vaccines. Additionally, the government is investing in healthcare infrastructure, which is making it easier for people to access healthcare services. The rise in population is also driving the demand for vaccines, as there are more people who need to be vaccinated.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
